Second primary malignancy after rituximab-containing immunochemotherapy for diffuse large B cell lymphoma.
Saved in:
| Title: | Second primary malignancy after rituximab-containing immunochemotherapy for diffuse large B cell lymphoma. |
|---|---|
| Authors: | Chinen, Yoshiaki1,2 (AUTHOR), Tanba, Kazuna1 (AUTHOR), Takagi, Ryo3 (AUTHOR), Uchiyama, Hitoji4 (AUTHOR), Uoshima, Nobuhiko5 (AUTHOR), Shimura, Kazuho6 (AUTHOR), Fuchida, Shin-ichi7 (AUTHOR), Kiyota, Miki8 (AUTHOR), Nakao, Mitsushige9 (AUTHOR), Tsukamoto, Taku2 (AUTHOR), Shimura, Yuji2 (AUTHOR), Kobayashi, Tsutomu2 (AUTHOR), Horiike, Shigeo2 (AUTHOR), Wada, Katsuya8 (AUTHOR), Shimazaki, Chihiro7 (AUTHOR), Kaneko, Hiroto6 (AUTHOR), Kobayashi, Yutaka5 (AUTHOR), Taniwaki, Masafumi6 (AUTHOR), Yokota, Isao3 (AUTHOR), Kuroda, Junya2 (AUTHOR) |
| Source: | Leukemia & Lymphoma. Dec2020, Vol. 61 Issue 14, p3378-3386. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
